127 research outputs found
Reconciling the interests of the economic diversification participants in a single-industry town
Рассматриваются проблемы согласования интересов участников процесса диверсификации экономики моногорода в процессе управления развитием моногорода на основе реализации стратегии диверсификации. Целью исследования является разработка инструментов гармонизации интересов участников процесса диверсификации экономики моногорода на основе разработки модели полного согласования интересов и сопоставления ее с моделью отдельно взятого моногорода. Методы исследования: системный подход, анализ и синтез, построение множеств согласования интересов с применением диаграммы Эйлера-Венна, методы комбинаторики, построение экономических показателей и рядов динамики, графический метод представления результатов и построения иерархии согласования интересов. Результаты исследования. Представлена модель полного согласования интересов различных групп лиц, в которой отражены сферы возможного пересечения интересов, а также иерархия числа согласуемых интересов. Предложены основные группы участников процесса диверсификации моногорода, а также разграничено понятие участника и роли (функции) участника в данном процессе. Обосновано и определено число множеств в зависимости от числа участников, чьи интересы одновременно согласуются, на примере моногорода Калтан Кемеровской области. На основе предложенной модели построена модель согласования интересов на примере моногорода Калтана. Полученная модель имеет трапециевидную форму, что свидетельствует о достаточно небольшом числе общих согласуемых интересов. Автор приходит к выводу, что в моногороде сформирован треугольник интересов «администрация города - малый бизнес в роли инвестора - вуз», представляющий основу в иерархии согласования интересов моногорода Калтан. Центральное положение при согласовании интересов с прочими участниками занимает исключительно администрация города. На основе данных выводов внесены предложения по направлениям дальнейшего согласования интересов на примере рассматриваемого моногорода.The article explores the problems of reconciling the interests of single-industry towns, a need that arises from the entire process of industry development management through a diversification strategy. The aim of this study is to develop tools to harmonize the interests of the single-industry towns, based on a model of full harmonization with the model of an individual single-industry town. Methods of the research: system approach, analysis and synthesis, building a set of harmonized interests with the application of the Eulerian-Venn diagram, combinatorics methods, construction of economic indicators and series of dynamics, graphical method of presentation of results and building the hierarchy of interests. Results of the study. The paper introduces the model for fully reconciling the interests of different groups of persons, reflecting the areas of possible intersecting interests and the hierarchy of the number of interests involved. The article proposes the main groups of participants in the diversification process and the differentially concept of participant and the role (function) of the participant in the diversification process. The author justifies and estimates the number of sets depending on the number of participants whose interests are concurrently reconciled in Kaltan case study. The proposed model is used for Kaltan, Kemerovo region case study. The result ing model is of a trapezoidal form, which indicates that there are quite a few common consenting interests. The author concludes that a triangle of interests «city administration - small business as investor - university» is formed. This triangle represents the highest level of harmonization of interests in the hierarchy. The city administration is in central position in reconciling interests with other participants. By the example of the considered single-industry town and based on these findings the suggestion on further harmonization of interests was made
Rankings as a comprehensive model to assess innovation and investment development of mesolevel economic systems (case of Tomsk region)
Актуальность определяется растущим интересом зарубежных и отечественных исследователей и практиков к рейтингам как комплексному методу оценки инновационно‐инвестиционого развития регионов. При этом нет единства мнений по методикам формирования рейтингов, отбора показателей и методов расчета. Цель работы: исследование и анализ рейтингов как модели комплексной оценки инновационного и инвестиционного развития экономических систем мезоуровня. Методы исследования: методы сравнительного, логического анализа, анализ и синтез, системный подход. Результаты. Представлен сравни‐ тельный анализ российских инновационно‐инвестиционных рейтингов; рассмотрены методики их составления и используемые системы показателей. Сформулированы ограничения рейтинга как модели комплексной оценки в целом, дана характеристика каждого отдельного рейтинга. В качестве примеров приведены позиции регионов Сибирского федерального округа в пяти российских рейтингах.The relevance of the topic is determined by the growing interest of foreign and domestic researchers and practitioners in ratings as a comprehensive method for assessing the innovative and investment development of the regions. At the same time there is no unity of opinion on the methods of rating formation, selection of indicators and calculation methods. The aim of the study is to research and analyze ratings as a model for integrated assessment of innovation and investment development of meso‐level economic systems. Methods of research: methods of comparative, logical analysis, analysis and synthesis, systematic approach. Results. The paper introduces the comparative analysis of Russian innovation and investment ratings, considers the methods of their compilation and the system of indicators. The rating constraints are formulated as a model of integrated assessment in general, and the characteristics of each individual rating are given. The authors give the positions of the regions of the Siberian Federal District in five Russian rankings as an example
Исследование и сравнительный анализ различных компоновок по характеру влияния на транспортирование шлама
Recruitment, augmentation and apoptosis of rat osteoclasts in 1,25-(OH)2D3 response to short-term treatment with 1,25-dihydroxyvitamin D3in vivo
Background
Although much is known about the regulation of osteoclast (OC) formation and activity, little is known about OC senescence. In particular, the fate of of OC seen after 1,25-(OH)2D3 administration in vivo is unclear. There is evidence that the normal fate of OC is to undergo apoptosis (programmed cell death). We have investigated the effect of short-term application of high dose 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) on OC apoptosis in an experimental rat model.
Methods
OC recruitment, augmentation and apoptosis was visualised and quantitated by staining histochemically for tartrate resistant acid phosphatase (TRAP), double staining for TRAP/ED1 or TRAP/DAPI, in situ DNA fragmentation end labelling and histomorphometric analysis.
Results
Short-term treatment with high-dose 1,25-(OH)2D3 increased the recruitment of OC precursors in the bone marrow resulting in a short-lived increase in OC numbers. This was rapidly followed by an increase in the number of apoptotic OC and their subsequent removal. The response of OC to 1,25-(OH)2D3 treatment was dose and site dependent; higher doses producing stronger, more rapid responses and the response in the tibiae being consistently stronger and more rapid than in the vertebrae.
Conclusions
This study demonstrates that (1) after recruitment, OC are removed from the resorption site by apoptosis (2) the combined use of TRAP and ED1 can be used to identify OC and their precursors in vivo (3) double staining for TRAP and DAPI or in situ DNA fragmentation end labelling can be used to identify apoptotic OC in vivo
Vitamin D prevents endothelial progenitor cell dysfunction induced by sera from women with preeclampsia or conditioned media from hypoxic placenta
Context: Placenta-derived circulating factors contribute to the maternal endothelial dysfunction underlying preeclampsia. Endothelial colony forming cells (ECFC), a sub-population of endothelial progenitor cells (EPCs), are thought to be involved in vasculogenesis and endothelial repair. Low vitamin D concentrations are associated with an increased risk for preeclampsia. Objective: We hypothesized that the function of human fetal ECFCs in culture would be suppressed by exposure to preeclampsia-related factors-preeclampsia serum or hypoxic placental conditioned medium- in a fashion reversed by vitamin D. Design, Setting, Patients: ECFCs were isolated from cord blood of uncomplicated pregnancies and expanded in culture. Uncomplicated pregnancy villous placenta in explant culture were exposed to either 2% (hypoxic), 8% (normoxic) or 21% (hyperoxic) O2 for 48 h, after which the conditioned media (CM) was collected. Outcome Measures: ECFC tubule formation (Matrigel assay) and migration were examined in the presence of either maternal serum from preeclampsia cases or uncomplicated pregnancy controls, or pooled CM, in the presence or absence of 1,25(OH)2 vitamin D3. Results: 1,25(OH)2 vitamin D3 reversed the adverse effects of preeclampsia serum or CM from hypoxic placenta on ECFCs capillary-tube formation and migration. Silencing of VDR expression by VDR siRNA, VDR blockade, or VEGF pathway blockade reduced ECFC functional abilities. Effects of VDR or VEGF blockade were partially prevented by vitamin D. Conclusion: Vitamin D promotes the capillary-like tubule formation and migration of ECFCs in culture, minimizing the negative effects of exposure to preeclampsia-related factors. Further evaluation of the role of vitamin D in ECFC regulation and preeclampsia is warranted. © 2014 Brodowski et al
Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative
Patients with rare and complex diseases such as congenital adrenal hyperplasia (CAH) often receive fragmented and inadequate care unless efforts are coordinated among providers. Translating the concepts of the medical home and comprehensive health care for individuals with CAH offers many benefits for the affected individuals and their families. This manuscript represents the recommendations of a 1.5 day meeting held in September 2009 to discuss the ideal goals for comprehensive care centers for newborns, infants, children, adolescents, and adults with CAH. Participants included pediatric endocrinologists, internal medicine and reproductive endocrinologists, pediatric urologists, pediatric surgeons, psychologists, and pediatric endocrine nurse educators. One unique aspect of this meeting was the active participation of individuals personally affected by CAH as patients or parents of patients. Representatives of Health Research and Services Administration (HRSA), New York-Mid-Atlantic Consortium for Genetics and Newborn Screening Services (NYMAC), and National Newborn Screening and Genetics Resource Center (NNSGRC) also participated. Thus, this document should serve as a “roadmap” for the development phases of comprehensive care centers (CCC) for individuals and families affected by CAH
Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative
Patients with rare and complex diseases such as congenital adrenal hyperplasia (CAH) often receive fragmented and inadequate care unless efforts are coordinated among providers. Translating the concepts of the medical home and comprehensive health care for individuals with CAH offers many benefits for the affected individuals and their families. This manuscript represents the recommendations of a 1.5 day meeting held in September 2009 to discuss the ideal goals for comprehensive care centers for newborns, infants, children, adolescents, and adults with CAH. Participants included pediatric endocrinologists, internal medicine and reproductive endocrinologists, pediatric urologists, pediatric surgeons, psychologists, and pediatric endocrine nurse educators. One unique aspect of this meeting was the active participation of individuals personally affected by CAH as patients or parents of patients. Representatives of Health Research and Services Administration (HRSA), New York-Mid-Atlantic Consortium for Genetics and Newborn Screening Services (NYMAC), and National Newborn Screening and Genetics Resource Center (NNSGRC) also participated. Thus, this document should serve as a “roadmap” for the development phases of comprehensive care centers (CCC) for individuals and families affected by CAH
Towards Rapid Multi-robot Learning from Demonstration at the RoboCup Competition
Abstract. We describe our previous and current efforts towards achiev-ing an unusual personal RoboCup goal: to train a full team of robots directly through demonstration, on the field of play at the RoboCup venue, how to collaboratively play soccer, and then use this trained team in the competition itself. Using our method, HiTAB, we can train teams of collaborative agents via demonstration to perform nontrivial joint behaviors in the form of hierarchical finite-state automata. We discuss HiTAB, our previous efforts in using it in RoboCup 2011 and 2012, recent experimental work, and our current efforts for 2014, then suggest a new RoboCup Technical Challenge problem in learning from demonstration. Imagine that you are at an unfamiliar disaster site with a team of robots, and are faced with a previously unseen task for them to do. The robots have only rudimentary but useful utility behaviors implemented. You are not a programmer. Without coding them, you have only a few hours to get your robots doing useful collaborative work in this new environment. How would you do this
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
Background
Real-world data on non-vitamin K oral anticoagulants (NOACs) are essential in determining whether evidence from randomised controlled clinical trials translate into meaningful clinical benefits for patients in everyday practice. RIVER (RIVaroxaban Evaluation in Real life setting) is an ongoing international, prospective registry of patients with newly diagnosed non-valvular atrial fibrillation (NVAF) and at least one investigator-determined risk factor for stroke who received rivaroxaban as an initial treatment for the prevention of thromboembolic stroke. The aim of this paper is to describe the design of the RIVER registry and baseline characteristics of patients with newly diagnosed NVAF who received rivaroxaban as an initial treatment.
Methods and results
Between January 2014 and June 2017, RIVER investigators recruited 5072 patients at 309 centres in 17 countries. The aim was to enroll consecutive patients at sites where rivaroxaban was already routinely prescribed for stroke prevention. Each patient is being followed up prospectively for a minimum of 2-years. The registry will capture data on the rate and nature of all thromboembolic events (stroke / systemic embolism), bleeding complications, all-cause mortality and other major cardiovascular events as they occur. Data quality is assured through a combination of remote electronic monitoring and onsite monitoring (including source data verification in 10% of cases). Patients were mostly enrolled by cardiologists (n = 3776, 74.6%), by internal medicine specialists 14.2% (n = 718) and by primary care/general practice physicians 8.2% (n = 417). The mean (SD) age of the population was 69.5 (11.0) years, 44.3% were women. Mean (SD) CHADS2 score was 1.9 (1.2) and CHA2DS2-VASc scores was 3.2 (1.6). Almost all patients (98.5%) were prescribed with once daily dose of rivaroxaban, most commonly 20 mg (76.5%) and 15 mg (20.0%) as their initial treatment; 17.9% of patients received concomitant antiplatelet therapy. Most patients enrolled in RIVER met the recommended threshold for AC therapy (86.6% for 2012 ESC Guidelines, and 79.8% of patients according to 2016 ESC Guidelines).
Conclusions
The RIVER prospective registry will expand our knowledge of how rivaroxaban is prescribed in everyday practice and whether evidence from clinical trials can be translated to the broader cross-section of patients in the real world
- …